Home NDC 49884-873 SAPROPTERIN DIHYDROCHLORIDE
Product NDC 49884-873
11-digit product format 498840873
Labeler code 49884
Product ID 49884-873_d9caf600-36bf-443b-bd05-cfeef3d84522
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name SAPROPTERIN DIHYDROCHLORIDE
Dosage form POWDER, FOR SOLUTION
Route ORAL
Labeler Par Health USA, LLC
Application ANDA210027
Marketing category ANDA
Marketing start 2020-10-01
Substance SAPROPTERIN DIHYDROCHLORIDE
Active strength 500 mg/1
Pharmacologic classes Breast Cancer Resistance Protein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Phenylalanine Hydroxylase Activator [EPC], Phenylalanine Hydroxylase Activators [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A210027-001 SAPROPTERIN DIHYDROCHLORIDE SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET FOR SOLUTION / ORAL AB 2019-08-20
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A210027-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL 2019-08-20 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL 2019-08-20 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 b00525d2431f…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET POWDER / ORAL AB 2019-08-20 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A210027-001 SAPROPTERIN DIHYDROCHLORIDE 500MG/PACKET FOR SOLUTION / ORAL AB 2019-08-20 a50c72e98297…
Observed Orange Book normalized TE history# Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2021-12-28 21:50 UTC 2021-12 A210027-001 PC 2021-03-30 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A210027-001 PC 2021-03-30 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A210027-001 PC 2021-03-30 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A210027-001 PC 2021-03-30 8869cabd3fbd…
Additional Listing Data#
Finished product Yes
Brand name base SAPROPTERIN DIHYDROCHLORIDE
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength SAPROPTERIN DIHYDROCHLORIDE 500 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination RG277LF5B3 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1653217 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 49884-873-52 SAPROPTERIN DIHYDROCHLORIDE 1 in 1 PACKET POWDER, FOR SOLUTION 1 24 49884-873-72 SAPROPTERIN DIHYDROCHLORIDE 30 in 1 CARTON POWDER, FOR SOLUTION 30 24
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 49884-873 SAPROPTERIN DIHYDROCHLORIDE POWDER, FOR SOLUTION [ENDO USA, INC.] 23 Current NDC, Legacy NDC, 2 package rows 20240713_2e13a3b5-e4df-4d5c-9b26-02a7006a7c3e.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 49884-873-52 49884087352 1 in 1 PACKET Historical 49884-873-72 49884087372 30 PACKET in 1 CARTON (49884-873-72) / 1 POWDER, FOR SOLUTION in 1 PACKET (49884-873-52) 30 packet 2020-10-01 0000-00-00 No No Current